Nanomaterials in drug delivery systems are emerging as a potential source of treatments. The bioavailability of nano-carriers depends upon various factors including their mode of administration, target specificity, availability of active compound and compatibility with biological system. Due to ingenious survival strategies many antibiotics become ineffective in the treatment of Staphylococcus spp. causing diseases. Though, nanosystems have been developed as an emerging approach to vanquish the obstacles for the treatment of Staphylococcus spp infections. Due to their encouraging and substantial outcomes, this review focused on the exploration of advances in nanosystems and their curing mechanism to control the infection of Staphylococcus spp. Several nanosystems are previously reported and compiled herein, which may use as a treatment of Staphylococcus causing diseases as well as inhibition of biofilm formation. Pathogenesis mechanisms such as immune clearance, membrane permeability and production of β-lactamase also described briefly in this review.
Keywords:
Published on: Aug 19, 2021 Pages: 49-55
Full Text PDF
Full Text HTML
DOI: 10.17352/2455-5363.000046
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."